Pursuant to Regulation 33 of SEBI LODR Regulations, 2015, we would like to inform you that the Board in its meeting held on August 05, 2026, has approved the unaudited financial results ....
RESULTS
▲ Positive Development
LOW RISK
📅 Filed on BSE: 05 Aug 2026, 06:00 PM IST · BSE ID: da077ed4-8ac2-4861-b05a-edddb885a91b
View Original BSE Filing (PDF)
💡
In Simple Terms
Bayer CropScience announced its first quarter financial results, showing a profit of 3,216 Million for the three months ending June 2026.
🤖 AI Summary
- Bayer CropScience reported Profit for the period of 3,216 Million for quarter ended June 30, 2026.
- Revenue from Operations stood at 18,350 Million for the quarter ended June 30, 2026.
- Total Income for the quarter was 19,239 Million, with Total Expenses at 15,218 Million.
- The Board of Directors approved these unaudited financial results on August 05, 2026.
- Earnings per share (basic and diluted) for the quarter was 71.56A.
🔢 Key Numbers — exact figures from BSE filing, not rounded
Revenue from Operations
18,350 Million
-4.16%
Other Income
889 Million
373.26%
Total Income
19,239 Million
-0.49%
Profit Before Tax
4,021 Million
19.96%
Profit for the period/year
3,216 Million
15.39%
Earnings per share (basic and diluted)
71.56A
15.40%
🏢 How This Affects the Company
The company's Revenue from Operations for Q1 FY27 decreased to 18,350 Million compared to 19,146 Million in Q1 FY26. Other Income included a Gain on Divestment of Marketing Rights for Formulated Products of 639 Million.
Profit for the period increased to 3,216 Million in Q1 FY27 from 2,787 Million in Q1 FY26. Earnings per share (basic and diluted) for the quarter rose to 71.56A from 62.01A in the comparable prior period.
Not directly relevant from the filing.
The company's business is seasonal in nature, and quarterly figures are not necessarily representative of the full year's performance.
👥 What This Means For Shareholders
✅
Action Required
No immediate action is required by shareholders based on this financial results disclosure.
👤
Who Is Affected
All shareholders are affected by the reported financial performance, specifically the increase in Profit for the period to 3,216 Million, which impacts the company's financial health.
🔍
Management Signal
The approval of the unaudited financial results signals management's adherence to regulatory disclosure requirements and provides an update on the company's financial standing.
For information only. Not investment advice. ForgeUp is not SEBI-registered.
👁 Watch List — track these upcoming events
Q2 FY27 unaudited financial results — check revenue and profit trends.
Updates on the contribution of Other Income to overall profitability.
Any further disclosures regarding the seasonality of the company's business.
LOW RISK
The filing indicates a seasonal business, but no new specific risks or adverse events were reported.
💡 Investor Takeaway
Bayer CropScience Ltd. reported a Profit for the period of 3,216 Million for Q1 FY27, up from 2,787 Million in Q1 FY26. Revenue from Operations, however, decreased to 18,350 Million from 19,146 Million in the prior comparable quarter.
⚖️ Strengths & Concerns
✅ Positives
- Profit for the period increased by 15.39% to 3,216 Million in Q1 FY27 compared to 2,787 Million in Q1 FY26.
- Other Income saw a significant rise to 889 Million, including 639 Million from divestment of marketing rights.
⚠️ Concerns
- Revenue from Operations decreased by 4.16% to 18,350 Million in Q1 FY27 from 19,146 Million in Q1 FY26.
- The company's Note 1 indicates that quarterly figures are not necessarily representative of the full year's performance due to seasonality.
📅 Company Track Record
Previous filings indicated Bayer CropScience Ltd.'s Board was to meet on August 05, 2026, to approve Q1 FY27 unaudited results, following a prior Q1 FY27 profit announcement of 3,216 Million on the same date. A board meeting in May 2026 was scheduled for FY26 results and a potential dividend.
Based on publicly available historical data. For context only.
❓ Frequently Asked Questions
What was Bayer CropScience's Profit for the period in Q1 FY27?
Bayer CropScience Ltd. reported an unaudited Profit for the period of 3,216 Million for the quarter ended June 30, 2026.
What was Bayer CropScience's Revenue from Operations for the quarter ended June 30, 2026?
Revenue from Operations for Bayer CropScience Ltd. was 18,350 Million for the quarter ended June 30, 2026.
How much did Bayer CropScience's Profit for the period change from Q1 FY26 to Q1 FY27?
Profit for the period increased by 15.39%, from 2,787 Million in Q1 FY26 to 3,216 Million in Q1 FY27.
What was the Earnings per share for Bayer CropScience in Q1 FY27?
Earnings per share (basic and diluted) for Bayer CropScience Ltd. was 71.56A for the quarter ended June 30, 2026.
Questions based on this BSE filing only. For information purposes.